Filing Details
- Accession Number:
- 0001415889-25-001496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-15 16:42:10
- Reporting Period:
- 2025-01-13
- Accepted Time:
- 2025-01-15 16:42:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals International Plc | KNSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1867899 | Eben Tessari | 23 Old Bond Street, Third Floor London X0 W1S 4PZ | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Acquisiton | 2025-01-13 | 7,000 | $3.80 | 102,975 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2025-01-13 | 12,323 | $18.13 | 90,652 | No | 4 | S | Direct | |
| Class A Ordinary Share | Disposition | 2025-01-13 | 1,677 | $19.08 | 88,975 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Share Option | Disposition | 2025-01-13 | 7,000 | $0.00 | 7,000 | $3.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,049 | 2027-06-28 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging between $17.92 and $18.89. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging between $18.92 and $19.39. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
